On May 11, 2023, the U.S. Food and Drug Administration (FDA) released a highly anticipated final guidance that recommends the adoption of individual donor assessment (IDA) to determine blood donor eligibility. Join us for this Hot Topic session where experts will discuss the research that helps to inform policy and implementation within the US and similar initiatives around the world. And for additional resources, check out AABB's Individual Donor Assessment webpage.
All relevant financial relationships have been mitigated.
By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.
AM23-TU-07-O: HOT TOPIC - Individual Donor Assessment (Enduring) Evaluation